Ulrich Bothner

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 3

Top Topics

Chronic Obstructive Pulmonary Disease

Community Dwelling

Top Venues

NPJ primary care respiratory medicine

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Gary T Ferguson, François Maltais, Jill Karpel, Ulrich Bothner, Isabel Kloer, Matthias Trampisch, Roland Buhl
Long-term safety of tiotropium/olodaterol in older patients with moderate-to-very-severe COPD in the TONADO® studies. NPJ primary care respiratory medicine 30 (1) (2020)
Cristina Rebordosa, Eline Houben, Kristina Laugesen, Ulrich Bothner, Jukka Montonen, Jaume Aguado, Jetty A Overbeek, Vera Ehrenstein, Joelle Asmar, Laura Wallace, Alicia W Gilsenan
No Evidence of Off-label Use of Olodaterol and Indacaterol in Denmark, France, and the Netherlands: A Drug Utilization Study. Scientific reports 10 (1) (2020)
Andrea Koch, Henrik Watz, M Reza Maleki-Yazdi, Ulrich Bothner, Kay Tetzlaff, Florian Voß, Lorcan McGarvey
Comprehensive assessment of the safety of olodaterol 5 µg in the Respimat® device for maintenance treatment of COPD: comparison with the long-acting β2-agonist formoterol. NPJ primary care respiratory medicine 27 (1) (2017)